GKM-19081-56965
3 vaccinations
4 coded responses
36 check-ins
4 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 762 / TX
- Registered
- 2022-08-05
- Relationship
- Child or adolescent in my care
- Guardian
- 5TE-75679-84709
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-08-05
Registered in v-safe
-
2022-08-05
Dose 1 — ModernaCo-administered: Hepatitis B:Hib:Other:Rotavirus:Tetanus
-
2022-08-05
Health check-in — day 0, dose 1, under 3Feeling: Fair · Site: Pain · Fever · Irritability/cryingUnder 3 check-in
-
2022-08-06
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Fever · Irritability/cryingUnder 3 check-in
- 2022-08-07
- 2022-08-09
- 2022-08-10
- 2022-08-11
-
2022-08-12
Survey response — day 7, dose 1, under 3MedDRA: Rhinorrhoea — Feeling: Poor · Fever · Irritability/crying, Diarrhea · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-08-12
Report sent to call center — day 7, dose 1, under 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-08-15
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-08-19
- 2022-08-28
- 2022-09-02
-
2022-09-08
Dose 2 — Moderna
-
2022-09-09
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Site: Pain · SleepinessUnder 3 check-in
-
2022-09-10
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Rhinorrhoea — Feeling: Fair · SleepinessFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-09-11
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Rhinorrhoea — Feeling: GoodFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-09-13
- 2022-09-14
- 2022-09-17
- 2022-09-22
- 2022-09-29
- 2022-10-06
-
2022-10-13
Survey response — day 35, dose 2, under 3MedDRA: Hand-foot-and-mouth disease — Feeling: Good · Be unable to work or attend schoolFree text: Hand foot mouth diseaseMedDRA releases: 2024-11 · check-in free text available
- 2022-10-20
- 2022-12-08
-
2023-02-16
Dose 3 — Moderna
- 2023-02-16
- 2023-02-17
- 2023-02-18
- 2023-02-19
- 2023-02-20
- 2023-02-21
- 2023-02-22
- 2023-02-23
- 2023-03-02
- 2023-03-09
- 2023-03-16
- 2023-03-23
- 2023-03-30
- 2023-05-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-08-05 | Moderna | Hepatitis B:Hib:Other:Rotavirus:Tetanus |
| 2 | 2022-09-08 | Moderna | No |
| 3 | 2023-02-16 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-08-12 | Successful 2022-08-15 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 12 (Under 3) — day 7, dose 1, under 3
Systemic reaction (other): Runny nose
Release 12 (Under 3) — days 1–6 daily, dose 2, under 3
Systemic reaction (other): Runny nose
Systemic reaction (other): Runny nose
Release 12 (Under 3) — day 35, dose 2, under 3
Symptoms: Hand foot mouth disease
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Hand-foot-and-mouth disease | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release